Browse
Recent Submissions
Item Radiation exposure in cardiac electrophysiology: a prospective observational study in a tertiary care centre(SCTIMST, 2022) Sundaram, CItem Study of outcomes in patient with prosthetic valve thrombosis(SCTIMST, 2022) Nitin NaikItem Long term outcome of Cardiac Pacemaker implantation in pediatric population(SCTIMST, 2022) Deepanjan BhattacharyaItem Item Clinical profile and outcomes of cardiomyopathy in children(SCTIMST, 2021) Gousia MukhtarItem Long term outcomes of percutaneous coronary intervention in patients with previous coronary artery bypass graft surgery(SCTIMST, 2021) Anil Kumar, BItem Clinical outcomes after cardiac resynchronization therapy: a single center experience(SCTIMST, 2021) Syed Nawaz AfzalItem Item Early and late outcomes after transcatheter aortic valve implantation(2021) Ankur AgarwalItem Comparison of oximetry with cardiac magnetic resonance imaging for estimation of flow in bidirectional glenn shunt(SCTIMST, 2021) Gayathri Bhuvaneswaran KarthaItem Arrhythmias in post surgical tetralogy of fallot patients(2021) Karthik, RItem Immediate and long term outcomes of balloon mitral valvotomy in juvenile mitral stenosis in comparison with adult mitral stenosis(SCTIMST, 2020-12-31) Shrusthi WaladItem Optical coherence tomography based characterisation of culprit lesions in acute coronary syndrome(SCTIMST, 2020-12-31) AVINASH MANIItem Morphological abnormalities in hypertrophic cardiomyopathy - a cardiac mri based study(SCTIMST, 2019-12) Vijayan GHypertrophic cardiomyopathy (HCM) has a varied clinical course due to its genotypic and phenotypic heterogeneity. Several autopsy studies have shown abnormalities of the mitral valve in some HCM patients. Cardiovascular magnetic resonance (CMR) has become the imaging modality of choice due to its high spatial resolution, well suited to define the diverse phenotypic expression of this complex disease. HCM has been documented to have various mitral valve abnormalities like an increased length of the leaflets and area, leaflet thickening, impaired mitral leaflet coaptation, and left ventricular outflow tract obstruction (LVOT) due to the systolic anterior motion of the mitral leaflets. Cardiovascular magnetic resonance (CMR) provides an excellent opportunity to assess the papillary muscle (PM) abnormalities like an increased number and mass, bifidity, hypertrophy, antero-apical displacement and LGE of the papillary muscle. Various guidelines recommend surgical myectomy as the preferred modality for patients with left ventricular outflow tract (LVOT) gradient ≥50 mm Hg who fail to respond to medications or who experience side effects. Alcohol septal ablation (ASA) in patients with mitral valve abnormalities results in persistent SAM, gradients, and mitral regurgitation (MR).Item Predictors of left atrial thrombus resolution in patients with mitral stenosis planned for percutaneous transvenous mitral commissurotomy(PTMC)(SCTIMST, 2019-12) Ravikanth TelikicherlaMitral stenosis (MS) is a common finding in Rheumatic Heart Disease (RHD). The current management of symptomatic mitral stenosis is Percutaneous Transvenous Mitral Commissurotomy (PTMC) unless it is contraindicated. The presence of Left Atrial Thrombus (LAT), however, is generally considered a contraindication to PTMC, leaving the open surgery as the treatment option. Left atrial thrombus occurs frequently in patients with Rheumatic Mitral Stenosis1 .Most of Left Atrial thrombus occurs in Left Atrial Appendage(LAA)2. The association of LAT in patients with MS and atrial fibrillation (AF) is well known3 . But it also occurs in patients with sinus rhythm (SR). And patients in Sinus Rhythm (SR) of rheumatic mitral stenosis were also noted to have larger LAA and poorer LAA contractile function3,4.This enhances stagnation and thrombus formation in the Left atrial appendage or Left atrium. The presence of thrombus increases the risk of systemic and peripheral embolism and it is a relative contraindication for PTMC. Framingham study showed 17 fold increase in risk of stroke for patients with AF and MS5. The reported incidence of LAT in severe Rheumatic MS is between 10% and 25%6,7,8 . Various studies have shown that Transesophageal Echocardiography(TEE) identifies Left atrial thrombus better than Transthoracic Echocardiography(TTE). The presence of LAT in patients with mitral Stenosis may alter the therapeutic approaches to the disease. In some circumstances, complete resolution of LAT can be achieved with oral anticoagulant therapy (OAC), allowing patients to undergo PTMC safely. Knowing the likelihood of LAT disappearance would help the physician to decide whether to proceed with surgical repair or to continue oral anticoagulation until LAT resolution and then to perform PTMC. The current management of severe MS is PTMC unless contraindicated. After complete resolution of LAT following adequate anticoagulation,2 these patients with severe MS can undergo PTMC without any added risk. Especially a model would help in predicting the likelihood of LA thrombus resolution, and hence, the treatment plan can be altered accordingly. Hence it is very essential to develop a model to identify patients who would respond to Oral anticoagulants on short term.